ISAC is deeply aware and appreciative of the massive efforts currently being undertaken by our Member Societies and global colleagues in fighting the SARS CoV-2 / COVID-19 pandemic.
The International Society of Antimicrobial Chemotherapy (ISAC) is a federation of affiliated Member Societies which aims to increase the knowledge of antimicrobial chemotherapy and combat antibiotic resistance around the world.
Creating sustainable meta-competence in the prevention, diagnosis and treatment of infectious diseases and control of antimicrobial resistance in order to improve global health.
ISAC encourages National and Regional Professional Societies active in antimicrobial chemotherapy, clinical microbiology and infectious diseases to affiliate.
Our 25 Working Groups on specialist subjects are engaged in advancing scientific knowledge in antimicrobial chemotherapy, clinical microbiology and infectious diseases through various activities.
The Alliance for the Prudent Use of Antibiotics (APUA) has merged with ISAC.
Deadline extended to 1 September! ISAC is now offering small Project Grants exclusively to applicants from ISAC Member Societies.
Impact Factors for both IJAA and JGAR have risen!
Read the latest issue and the open access Editor's Choice articles
We are pleased to bring you the Summer 2020 issue of the APUA / ISAC Newsletter.
We are deeply saddened to announce the passing of two highly respected colleagues - Dr Adel Al-Othman and Prof. Keiichi Hiramatsu.
The deadline to submit an application for an ISAC Project Grant has now been extended until 1 September 2020!
The 32nd International Congress of Antimicrobial Chemotherapy (ICC) will be held in partnership with the Australian Society for Antimicrobials in Perth, Australia from 21 - 24 November 2021.
Sign up for the latest news and events straight to your inbox